drugset / Trial / NCT06988059
A Study of CT0596 in Plasma Cell Leukemia
Phase 0
Recruiting
27 enrolled
Institute of Hematology & Blood Diseases Hospital, China
CARsgen Therapeutics Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, open-label, exploratory dose-escalation and dosefinding clinical trial to evaluate the safety, efficacy, cellular pharmacokinetics and pharmacodynamics of CT0596 cells in patients with PCL.
Timeline
- Start
- 2025-06-25
- Primary completion
- 2027-01-03
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT0596 | Cell therapy | — | — |